Therapeutic angiogenesis for peripheral artery disease: Gene therapy

Vasa - Journal of Vascular Diseases

Volumn 36, Issue 3, 2007, Pages 165-173

  Nikol, Sigrid ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Angiogenesis; Gene therapy; Growth factor; Limb ischaemia; Peripheral artery disease

Indexed keywords

ADENOVIRUS VECTOR; ANGIOGENIC FACTOR; CYTOKINE; DIURETIC AGENT; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PLACEBO; PLASMID DNA; SCATTER FACTOR; VASCULOTROPIN; VASCULOTROPIN 121; VASCULOTROPIN 165; VASCULOTROPIN A; VASCULOTROPIN C;

AMPUTATION; ANGIOGENESIS; ANGIOGENIC GENE THERAPY; AORTA; ARTERY DISEASE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARCINOGENESIS; CARDIOVASCULAR SYMPTOM; CLINICAL TRIAL; CONGENITAL BLOOD VESSEL MALFORMATION; CONTROLLED CLINICAL TRIAL; DRUG MECHANISM; DRUG MEGADOSE; GERM LAYER; HUMAN; LIMB ISCHEMIA; LOW DRUG DOSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL EDEMA; PERIPHERAL ISCHEMIA; REVIEW; SINGLE DRUG DOSE; STEM CELL; STEM CELL TRANSPLANTATION; UNSPECIFIED SIDE EFFECT; VASCULAR SMOOTH MUSCLE;

ANGIOGENIC PROTEINS; ANIMALS; ENDOTHELIAL CELLS; EXTREMITIES; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; ISCHEMIA; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PHYSIOLOGIC; PERIPHERAL VASCULAR DISEASES; STEM CELLS; TREATMENT OUTCOME;

EID: 34548255902     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.36.3.165     Document Type: Review

References (63)

1. Asahara T, Kalka C, Isner JM. Stem cell therapy and gene transfer for regeneration. Gene Ther 2000; 7(6): 451-7.
2. Bahary N, Zon LI. Development. Endothelium-chicken soup for the endoderm. Science 2001; 294(5542): 530-1.
3. Baumgartner I, Chronos N, Comerota AJ, Henry TD, Pasquet JP, Dedieu JF, et al. In vivo distribution and expression of FGF1 transgene in patients with severe peripheral arterial occlusive disease (PAD). Circulation 2004; 110(17): III-520.
4. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998; 97(12): 1114-23.
5. Bottinger EP, Letterio JJ, Roberts AB. Biology of TGF-beta in knockout and transgenic mouse models. Kidney Int 1997; 51(5): 1355-60.
6. Breier G, Albrecht U, Sterrer S, Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 1992; 114(2): 521-32.
7. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6(4): 389-95.
8. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9(6): 653-60.
9. Carmeliet P, Collen D. Molecular basis of angiogenesis. Role of VEGF and VE-cadherin. Ann N Y Acad Sci 2000; 902: 249-62; discussion 262-4.
10. Carmeliet P, Collen D. Transgenic mouse models in angiogenesis and cardiovascular disease. J Pathol 2000; 190(3): 387-405.
11. Cleaver O, Melton DA. Endothelial signaling during development. Nat Med 2003; 9(6): 661-8.
12. Damert A, Machein M, Breier G, Fujita MQ, Hanahan D, Risau W, et al. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res 1997; 57(17): 3860-4.
13. DeRuiter MC, Gittenberger-de Groot AC, Poelmann RE, VanIperen L, Mentink MM. Development of the pharyngeal arch system related to the pulmonary and bronchial vessels in the avian embryo. With a concept on systemic-pulmonary collateral artery formation. Circulation 1993; 87(4): 1306-19.
14. DeRuiter MC, Poelmann RE, VanMunsteren JC, Mironov V, Markwald RR, Gittenberger-de Groot AC. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res 1997; 80(4): 444-51.
15. Diehm C, Schuster A, Allenberg JR, Darius H, Haberl R, Lange S, et al. High prevalence of peripheral arterial disease and comorbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004; 172(1): 95-105.
16. Dieterlen-Lievre F, Jaffredo T, Pardanaud L. Emergence of the endothelial network during embryonic development. Pathol Biol 1999; 47(4): 301-6.
17. Dormandy J, Rutherford R, Heeck L, Schroeder S, Moore H. Management of Peripheral Arterial Disease (PAD). TransAtlantic Inter-Society Consensus (TASC). J Vasc Surgery 2000; 31(1 part 2).
18. Ferrara N. Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol 1999; 237: 1-30.
19. Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 1995; 333(26): 1757-63.
20. Gerwins P, Skoldenberg E, Claesson-Welsh L. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit Rev Oncol Hematol 2000; 34(3): 185-94.
21. Gibson CM, Ryan K, Sparano A, Moynihan JL, Rizzo M, Kelley M, et al. Angiographic methods to assess human coronary angiogenesis. Am Heart J 1999; 137(1): 169-79.
22. Harada K, Friedman M, Lopez JJ, Wang SY, Li J, Prasad PV, et al. Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol 1996; 270(5 Pt 2): H1791-802.
23. Hautmann MB, Madsen CS, Owens GK. A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements. J Biol Chem 1997; 272(16): 10948-56.
24. Hedman M, Hartikainen J, Syvanne M, Stjernvall J, Hedman A, Kivela A, et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 2003; 107(21): 2677-83.
25. Helisch A, Schaper W. Angiogenesis and arteriogenesis - not yet for prescription. Z Kardiol 2000; 89(3): 239-44.
26. Hirschi KK, Rohovsky SA, D'Amore PA. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 1998; 141(3): 805-14.
27. Isner JM, Baumgartner I, Rauh G, Schainfeld R, Blair R, Manor O, et al. Treatment of thromboangiitis obliterans (Buergers disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surgery 1998; 28: 964-75.
28. Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, et al. Clinical evidence of angiogenesis following arterial gene transfer of phVEGF165. Lancet 1996; 348: 370-74.
29. Kastrup J, Jorgensen E, Ruck A, Tagil K, Glogar D, Ruzyllo W, et al. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial. J Am Coll Cardiol 2005; 45(7): 982-8.
30. Korn J, Christ B, Kurz H. Neuroectodermal origin of brain pericytes and vascular smooth muscle cells. J Comp Neurol 2002; 442(1): 78-88.
31. Korpelainen EI, Alitalo K. Signaling angiogenesis and lymphangiogenesis. Curr Opin Cell Biol 1998; 10(2): 159-64.
32. Kroll J, Waltenberger J. Regulation of the endothelial function and angiogenesis by vascular endothelial growth factor-A (VEGF-A. Z Kardiol 2000; 89(3): 206-18.
33. Kuhlmann M, Klocke R, Nikol S. Therapeutic angiogenesis for peripheral artery disease - Cytokine therapy. VASA 2007; (in press).
34. Kusumanto YH, van Weel V, Mulder NH, Smit AJ, van den Dungen JJ, Hooymans JM, et al. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. Hum Gene Ther 2006; 17(6): 683-91.
35. Lachmann N, Nikol S. Therapeutic angiogenesis for peripheral artery disease - Stem cell therapy. VASA 2007; (in press).
36. Laitinen M, Makinen K, Manninen H, Matsi P, Kossila M, Agrawal RS, et al. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum Gene Ther 1998; 9(10): 1481-6.
37. Le Lievre CS, Le Douarin NM. Mesenchymal derivatives of the neural crest: analysis of chimaeric quail and chick embryos. J Embryol Exp Morphol 1975; 34(1): 125-54.
38. Lopez JJ, Edelman ER, Stamler A, Hibberd MG, Prasad P, Caputo RP, et al. Basic fibroblast growth factor in a porcine model of chronic myocardial ischemia: a comparison of angiographic, echocardiographic and coronary flow parameters. J Pharmacol Exp Ther 1997; 282(1): 385-90.
39. Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M, et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998; 98(25): 2800-4.
40. Mack CA, Magovern CJ, Budenbender KT, Patel SR, Schwarz EA, Zanzonico P, et al. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. J Vasc Surg 1998; 27(4): 699-709.
41. Majesky MW, Schwartz SM. An origin for smooth muscle cells from endothelium? Circ Res 1997; 80(4): 601-3.
42. Makinen K, Manninen H, Hedman M, Matsi P, Mussalo H, Alhava E, et al. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mol Ther 2002; 6(1): 127-33.
43. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994; 8(4): 345-51.
44. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 1993; 88(3): 837-45.
45. Ng YS, D'Amore PA. Therapeutic angiogenesis for cardiovascular disease. Curr Control Trials Cardiovasc Med 2001; 2(6): 278-85.
46. Nikol S, VanBelle E, Diehm C, Visona A, Capogrossi M, Ferreira-Maldent N, et al. Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-Free Survival in Patients With Critical Limb Ischemia. Late braking trials 2006; ACC 2006: http://acc06online.acc.org/Lectures.
47. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33 Suppl 1: S1-75.
48. Ogawa S, Oku A, Sawano A, Yamaguchi S, Yazaki Y, Shibuya M. A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. J Biol Chem 1998; 273(47): 31273-82.
49. Pardanaud L, Luton D, Prigent M, Bourcheix LM, Catala M. Dieterlen-Lievre F. Two distinct endothelial lineages in ontogeny, one of them related to hemopoiesis. Development 1996; 122(5): 1363-71.
50. Rajagopalan S, Olin J, Deitcher S, Pieczek A, Laird J, Grossman PM, et al. Use of a Constitutively Active Hypoxia-Inducible Factor-1{alpha} Transgene as a Therapeutic Strategy in No-Option Critical Limb Ischemia Patients: Phase I Dose-Escalation Experience. Circulation 2007; 150(10): 1234-43.
51. rd, Lederman RJ, Mendelsohn FO, Saucedo JF, Goldman CK, et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 2003; 108(16): 1933-8.
52. Risau W. Mechanisms of angiogenesis. Nature 1997; 386(6626): 671-4.
53. Rissanen TT, Korpisalo P, Markkanen JE, Liimatainen T, Orden MR, Kholova I, et al. Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis. Circulation 2005; 112(25): 3937-46.
54. Rissanen TT, Vajanto I, Yla-Herttuala S. Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb - on the way to the clinic. Eur J Clin Invest 2001; 31(8): 651-66.
55. Rosenquist TH, Beall AC. Elastogenic cells in the developing cardiovascular system. Smooth muscle, nonmuscle, and cardiac neural crest. Ann N Y Acad Sci 1990; 588: 106-19.
56. Schumacher B, Pecher P, von Specht BU, Stegmann T. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 1998; 97(7): 645-50.
57. Shah NM, Groves AK, Anderson DJ. Alternative neural crest cell fates are instructively promoted by TGFbeta superfamily members. Cell 1996; 85(3): 331-43.
58. Simons M, Bonow RO, Chronos NA, Cohen DJ, Giordano FJ, Hammond HK, et al. Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary. Circulation 2000; 102(11): E73-86.
59. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 1994; 93(2): 662-70.
60. van Royen N, Piek JJ, Buschmann I, Hoefer I, Voskuil M, Schaper W. Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. Cardiovasc Res 2001; 49(3): 543-53.
61. Wells SM, Langille BL, Lee JM, Adamson SL. Determinants of mechanical properties in the developing ovine thoracic aorta. Am J Physiol 1999; 277(4 Pt 2): H1385-91.
62. Yla-Herttuala S, Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 2003; 9(6): 694-701.
63. Ylä-Herttuala S, Rissanen TT, Vajanto I, Hartikainen J. Vascular Endothelial Growth Factors: Biology and Current Status of Clinical Applications in Cardiovascular Medicine. J Am Coll Cardiol 2007; 49(10): 1015-26.